Barth syndrome mutations that cause tafazzin complex lability

SM Claypool, K Whited, S Srijumnong, X Han… - Journal of cell …, 2011 - rupress.org
SM Claypool, K Whited, S Srijumnong, X Han, CM Koehler
Journal of cell biology, 2011rupress.org
Deficits in mitochondrial function result in many human diseases. The X-linked disease
Barth syndrome (BTHS) is caused by mutations in the tafazzin gene TAZ1. Its product,
Taz1p, participates in the metabolism of cardiolipin, the signature phospholipid of
mitochondria. In this paper, a yeast BTHS mutant tafazzin panel is established, and 18 of the
21 tested BTHS missense mutations cannot functionally replace endogenous tafazzin. Four
BTHS mutant tafazzins expressed at low levels are degraded by the intermembrane space …
Deficits in mitochondrial function result in many human diseases. The X-linked disease Barth syndrome (BTHS) is caused by mutations in the tafazzin gene TAZ1. Its product, Taz1p, participates in the metabolism of cardiolipin, the signature phospholipid of mitochondria. In this paper, a yeast BTHS mutant tafazzin panel is established, and 18 of the 21 tested BTHS missense mutations cannot functionally replace endogenous tafazzin. Four BTHS mutant tafazzins expressed at low levels are degraded by the intermembrane space AAA (i-AAA) protease, suggesting misfolding of the mutant polypeptides. Paradoxically, each of these mutant tafazzins assembles in normal protein complexes. Furthermore, in the absence of the i-AAA protease, increased expression and assembly of two of the BTHS mutants improve their function. However, the BTHS mutant complexes are extremely unstable and accumulate as insoluble aggregates when disassembled in the absence of the i-AAA protease. Thus, the loss of function for these BTHS mutants results from the inherent instability of the mutant tafazzin complexes.
rupress.org